These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 33078588)
1. Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer. Chang JS; Kim N; Kim JY; Do SI; Cho Y; Kim HS; Kim YB J Gynecol Oncol; 2020 Nov; 31(6):e78. PubMed ID: 33078588 [TBL] [Abstract][Full Text] [Related]
2. Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer. Yousef GM; Scorilas A; Kyriakopoulou LG; Rendl L; Diamandis M; Ponzone R; Biglia N; Giai M; Roagna R; Sismondi P; Diamandis EP Clin Chem; 2002 Aug; 48(8):1241-50. PubMed ID: 12142380 [TBL] [Abstract][Full Text] [Related]
3. KLK5 is associated with the radioresistance, aggression, and progression of cervical cancer. Zhou S; Liu S; Tian G; Zhao L; Wang H; Li Y; Shen Y; Han L Gynecol Oncol; 2022 Jul; 166(1):138-147. PubMed ID: 35595569 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of kallikrein 5 as a novel prognostic biomarker in gastric adenocarcinoma. Abuduhadeer X; Xu X; Aihesan K; Yilihamu M; Zhao Y; Zhang W J Clin Lab Anal; 2021 Oct; 35(10):e23958. PubMed ID: 34510543 [TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer. Gong W; Liu Y; Seidl C; Diamandis EP; Kiechle M; Drecoll E; Kotzsch M; Magdolen V; Dorn J BMC Cancer; 2019 Jul; 19(1):696. PubMed ID: 31307411 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of kallikrein‑related peptidase 5 is associated with the malignant behavior of colorectal cancer. Wu Y; Chen Y; Li Q; Gong Y; Liu X; Bi L; Hu C Mol Med Rep; 2016 Sep; 14(3):2164-70. PubMed ID: 27430713 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer. Gong W; Liu Y; Diamandis EP; Kiechle M; Bronger H; Dorn J; Dreyer T; Magdolen V J Ovarian Res; 2020 Oct; 13(1):125. PubMed ID: 33087135 [TBL] [Abstract][Full Text] [Related]
9. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer. Kim H; Scorilas A; Katsaros D; Yousef GM; Massobrio M; Fracchioli S; Piccinno R; Gordini G; Diamandis EP Br J Cancer; 2001 Mar; 84(5):643-50. PubMed ID: 11237385 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues. Yousef GM; Scorilas A; Chang A; Rendl L; Diamandis M; Jung K; Diamandis EP Prostate; 2002 May; 51(2):126-32. PubMed ID: 11948967 [TBL] [Abstract][Full Text] [Related]
11. [Risk factors and prognosis of node-positive cervical carcinoma]. Feng SY; Zhang YN; Liu JG Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145 [TBL] [Abstract][Full Text] [Related]
12. Para-aortic lymph node recurrence after curative radiotherapy for cervical cancer. Cho WK; Kim YI; Park W; Yang K; Kim H; Cha H Int J Gynecol Cancer; 2019 Sep; 29(7):1116-1120. PubMed ID: 31474588 [TBL] [Abstract][Full Text] [Related]
13. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study]. Wang W; Shang C; Huang J; Chen S; Shen H; Yao S Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy. Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745 [TBL] [Abstract][Full Text] [Related]
15. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111 [TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in definitive radiotherapy of uterine cervical cancer. Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer. Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253 [TBL] [Abstract][Full Text] [Related]
18. C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer. Zhang W; Ou J; Lei F; Hou T; Wu S; Niu C; Xu L; Zhang Y Tumour Biol; 2016 Jan; 37(1):369-79. PubMed ID: 26219895 [TBL] [Abstract][Full Text] [Related]
19. B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer. Zhang W; Hou T; Niu C; Song L; Zhang Y PLoS One; 2015; 10(12):e0144360. PubMed ID: 26709519 [TBL] [Abstract][Full Text] [Related]
20. Tumor-related leukocytosis is associated with poor radiation response and clinical outcome in uterine cervical cancer patients. Cho Y; Kim KH; Yoon HI; Kim GE; Kim YB Ann Oncol; 2016 Nov; 27(11):2067-2074. PubMed ID: 27502717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]